References
Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 2011; 118: 4024635.
Kempf W. CD30+ lymphoproliferative disorders: Histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol 2006; 33: 58–70.
Kempf W, Mitteldorf C, Karai LJ, Robson A. Lymphomatoid papulosis-Making sense of the alphabet soup: a proposal to simplify terminology. J Dtsch Dermatol Ges 2017; 15: 390–4.
Karai LJ, Kadin ME, Hsi ED, et al. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J Surg Pathol 2013; 37: 1173–81.
de la Garza Bravo MM, Patel KP, Loghavi S, et al. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol 2015; 46: 558–69.
Kodama K, Fink-Puches R, Massone C, Kerl H, Cerroni L. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides. J Am Acad Dermatol 2005; 52: 694–8.
Heald P, Subtil A, Breneman D, Wilson LD. Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma. J Am Acad Dermatol 2007; 57: 1005–11.
Pileri A, Bacci F, Neri I, et al. Persistent agmination of lymphomatoid papulosis: an ongoing debate. Dermatology 2012; 225: 131–4.
Csomor J, Eros N, Szepesi A, et al. Persistent agmination of lymphomatoid papulosis: a new case with immunohistopathologically confirmed mycosis fungoides component. J Am Acad Dermatol 2011; 65: e98–100.
Endo C, Naka Y, Miyagaki T, et al. Immunophenotypic shift from CD4(+) to CD8(+) in mycosis fungoides. Br J Dermatol 2016; 175: 830–3.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hori-Kosogabe, J., Hamada, T., Morizane, S. et al. TypeD(CD8+) lymphomatoid papulosis in a patient with classic (CD4+) mycosis fungoides. Eur J Dermatol 28, 267–268 (2018). https://doi.org/10.1684/ejd.2018.3234
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3234